TrialDrug design, development and therapy2026

Safety and Pharmacokinetics of SRN001, a Novel siRNA Drug Targeting Amphiregulin via the SAMiRNA Platform.

Jiyeon Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.